F

FZata, Inc.

9 employees

Fzata's novel platform modality for oral biologics is Bioengineered Probiotic Yeast Medicines (BioPYM) with over 10 GI drug candidates.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Pharmaceutical

Therapeutics

microbiota

Biologics

Nanobodies

Medical

Gastrointestinal

Antibodies

Date founded

2015

FAQ